Jeff Sharpe
Jeff Sharpe
Drawing on a track record of entrepreneurial success, Jeff spearheaded multiple ventures, including a Canadian biotech that went from startup to IPO, raising $30M in 9 months. He has guided numerous private companies to public listings, generating over $100M in combined private and public market financing, with deep expertise in IPOs and M&A. Recognized among Canada’s Top 40 Under 40 for his leadership at his own national start-up. As an active investor and advisor, Jeff remains focused on public-market biotech, guiding emerging companies to accelerate growth and achieve successful exits.